-
March 11, 2021 Ketamine Therapy May Help Slow Progression of ALSNew research is looking at ketamine therapy as a potential aid in slowing the deadly...
-
March 10, 2021 Core One Labs and Ketamine Infusion Centers to Explore DMT Therapy for Anxiety and DepressionCore One Labs is exploring DMT therapy for anxiety and depression in a partnership with...
-
March 10, 2021 Beckley Psytech Explores Psilocybin for Headache TreatmentA new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting...
-
March 10, 2021 Canada’s First End of Life Psilocybin Treatment Brought Peace to Terminal ManTony White may have lost his battle with cancer, but becoming the first end of...
-
March 10, 2021 Are ‘Magic’ Psilocybin Truffles the Fountain of Youth? New Study Looks at Anti-Aging BenefitsNew research is looking at psilocybin truffles as a potential anti-aging tool and aid in...
-
March 9, 2021 Can An App Give You a Psychedelic Experience Without Taking Drugs? Lumenate Says YesLumenate is an app that simulates a psychedelic experience without the need for illegal substances.
-
March 9, 2021 Minority Veterans Organization Urges Congress to Loosen Restrictions on Psychedelic TherapiesA minority veterans organization wants access to psychedelic therapies for PTSD and depression. It's urging...
-
March 9, 2021 Are Microdosing Benefits Real? A New Study Says It May All Be In Your MindMIcrodosing with psychedelics is gaining in popularity but new research says the placebo effect worked...
-
March 9, 2021 Defiance Just Launched the World’s Second Psychedelics-Focused ETFDefiance has launched the world's second psychedelics-focused ETF as investing in psychedelic therapy and treatment...
-
March 8, 2021 Survey: More Than 30% Of Psychedelic Users Are Self-Treating Mental Health IssuesMore than 30% of survey participants say they're treating their mental health issues independently with...
